Investing.com - Financial Markets Worldwide

HCA stock hits all-time high at 439.32 USD

Published 22/10/2025, 17:38
HCA stock hits all-time high at 439.32 USD
HCA
0.54%

HCA Holdings Inc. reached an all-time high with its stock price hitting 439.32 USD. This milestone reflects a significant confidence boost among investors, with the healthcare giant’s impressive 42.83% year-to-date return and substantial market capitalization of $102.6 billion. According to InvestingPro analysis, the stock is currently trading near its Fair Value. The healthcare services provider continues to demonstrate resilience and growth potential in a challenging market, generating robust annual revenue of $72.7 billion and maintaining a GREAT financial health score. This achievement underscores the company’s robust performance and strategic initiatives that have resonated well within the investment community. InvestingPro subscribers can access 11 more exclusive tips and a comprehensive Pro Research Report for deeper insights into HCA’s performance metrics.

In other recent news, HCA Healthcare has seen several analyst updates that could interest investors. Goldman Sachs initiated coverage on HCA Healthcare with a Buy rating and set a price target of $470. This positive outlook is based on the company’s ability to adapt to industry challenges effectively. Cantor Fitzgerald reiterated its Overweight rating with a $444 price target, highlighting a favorable setup for the upcoming third-quarter 2025 earnings report. The firm also noted an increase in job openings with bonuses across nursing specialties, indicating successful recruitment strategies.

Bernstein maintained a Market Perform rating, setting a price target of $417, following discussions on HCA’s use of AI and digital technologies to enhance healthcare delivery. RBC Capital raised its price target to $449 from $404, maintaining an Outperform rating due to HCA’s strong market positioning and industry-leading margins. These developments reflect a range of analyst perspectives on HCA Healthcare’s current and future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.